Invesco Ltd. - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 186 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,048,469
-14.3%
134,938
+6.7%
0.00%
Q2 2023$1,223,813
-11.9%
126,427
-0.2%
0.00%
Q1 2023$1,388,752
+289.3%
126,711
+53.4%
0.00%
Q4 2022$356,758
-46.4%
82,583
-6.6%
0.00%
Q3 2022$665,000
-23.4%
88,451
+2.3%
0.00%
Q2 2022$868,000
+114.3%
86,466
+164.0%
0.00%
Q1 2022$405,000
+55.2%
32,751
+187.0%
0.00%
Q4 2021$261,000
-19.4%
11,411
-22.0%
0.00%
Q3 2021$324,000
+39.1%
14,629
-18.6%
0.00%
Q2 2021$233,000
+385.4%
17,971
+69.9%
0.00%
Q4 2017$48,00010,5780.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders